Showing the single result
Your physician has prescribed Trelegy to you for asthma or COPD. Because your healthcare provider has a thorough assessment of your overall health, you should follow your physician’s instructions about dosing and administration of Trelegy Ellipta. Never ignore the advice of your prescriber, as they have a complete understanding of your general health. Trelegy is usually taken once every 24 hours.
If you are almost due for your next dose, skip the missed dose and take medicine as soon as possible. Two doses should not be taken at once.
You should not use more than one dose per day.
It may be better to use two separate inhalers instead of the Trelegy Ellipta triple therapy inhaler – the Breo Ellipta (fluticasone/vilanterol) and the Incruse Ellipta (umeclidinium). For maintenance treatment of asthma or COPD, you need two prescription inhalers instead of just one. In addition, you should keep an albuterol inhaler (ProAir, Proventil, Ventolin) close by in case of sudden symptoms.
For the treatment of COPD and asthma, Trelegy Ellipta is a once-daily triple-drug inhaler that must be used daily. There is no need to use inhalers such as Trelegy Ellipta as rapid-acting rescue inhalers during sudden breathing difficulties. The medication is used to prevent flare-ups over the long term.
Each medication has a different effect on each individual. Depending on your last treatment, symptoms, the state of your lungs, and tolerance, this medicine will work more quickly for you. You can get a timeline of your treatment response from your physician since they know your medical condition best.
Taking Trelegy Ellipta as prescribed is essential, even if you feel well. Symptoms are controlled with this medication. Regular use makes it most effective. Consult your physician, doctor, or healthcare provider if you miss a dose.
Carefully read and follow all the instructions that come with the inhaler. In case you have any questions, ask your doctor or pharmacist.
You cannot use Trelegy to treat bronchospasm. A severe attack should only be treated with a fast-acting inhalation medicine (e.g., albuterol). Get a prescription from your doctor if you don’t have a fast-acting inhaler. If your breathing problems worsen quickly, call 911 or seek emergency medical attention.
Both COPD and asthma can be treated with Trelegy.
There have been no reports of weight gain during treatment of asthma or chronic obstructive pulmonary disease (COPD) using Trelegy Ellipta. To evaluate Trelegy’s side effects, studies lasting 12 weeks, 24 weeks, and one year were conducted by the manufacturer.
Weight gain has rarely been associated with long-term use of inhaled corticosteroids (“steroids”). Using oral steroids (such as prednisone) is linked to weight gain. However, fluticasone is absorbed locally into the lung and has a comparatively low systemic effect.
Breo Ellipta and Trelegy Ellipta are long-term maintenance treatment options for asthma and COPD (chronic bronchitis, emphysema, or both).
Three medications are included in Trelegy Ellipta: fluticasone, an inhaled corticosteroid, vilanterol, a long-acting beta-agonist (LABA), and umeclidinium, an anticholinergic drug. Fluticasone and vilanterol are the two medications found in Breo Ellipta. Neither should be used together.
By lowering inflammation in the lungs and relaxing the airways in patients with asthma or COPD, these medicines can improve breathing symptoms and reduce flare-ups. However, they cannot control sudden problems with breathing.
Fluticasone furoate, umeclidinium, and vilanterol are the active ingredients in Trelegy Ellipta dry powder oral inhalation agent.
In adults aged 18 years and older, Trelegy Ellipta is approved for use as a maintenance treatment of COPD and asthma. Acute bronchospasm is not treated with Trelegy Ellipta.
As a treatment, Trelegy Ellipta should be inhaled once per day.